Cancer research consortium gets $50M from Celgene

Celgene Corp. (NASDAQ:CELG) will provide $50 million for access to research conducted by a newly created consortium of four academic cancer centers as part of a 10-year research collaboration.

The not-for-profit The Cancer Trust assembled the consortium, which includes the Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, and The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. ...